NCT02908711View on ClinicalTrials.gov

Adductor Canal Block (ACB) Before and After Primary Total Knee Arthroplasty (TKA)

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Anesthesia, Regional
Interventions
DRUG

0.5% ropivacaine

Adductor canal block (ACB) performed as part of their analgesic regimen for primary total knee arthroplasty achieved with 20 cc of 0.5% ropivacaine under constant ultrasound visualization.

Trial Locations (1)

Unknown

Rabin Medical Center, Petach Tikvah

All Listed Sponsors
lead

Rabin Medical Center

OTHER

NCT02908711 - Adductor Canal Block (ACB) Before and After Primary Total Knee Arthroplasty (TKA) | Biotech Hunter | Biotech Hunter